Select Publications

Journal articles

Moore JJ; Ma DD; Will R; Cannell P; Handel ML; Milliken ST, 2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, 34, pp. 241 - 247, http://www.sciencedirect.com/science/article/B6WVB-4CX0S62-K6/2/82576fabf01404bdf5cb9daf484bfd5d

Snowden J; Passweg J; Moore JJ; Milliken ST; Cannell P; Van Laar J; Verburg R; Szer J; Taylor KM; Joske D; Rule S; Bingham S; Emery P; Burt R; Lowenthal RM; Durez P; McKendry R; Pavletic S; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks PM; Bredeson C; Tyndall A, 2004, 'Autologous hemopoietic stem cell transplantation in severe rheumatoidarthritis: A report from the EBMT and ABMTR', Journal of Rheumatology, 31, pp. 482 - 488

Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, 8, pp. 2765 - 2765

Moore JJ; Ma DD; Dodds T; Milliken ST; Fay K; Concannon A; smith I, 2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, 104, pp. 371B - 371B

Bingham S; Moore JJ, 2004, 'Rheumatoid arthritis', Best Practice and Research Clinical Haematology, 17, pp. 263 - 276, http://www.sciencedirect.com/science/article/B6WBG-4D1TPYX-7/2/eb0d083ddca8cebd0b3fee780a2cd458

Moore JJ; Johnston AM; David M; Sam MJ; Keith F; Tony D, 2004, 'Treatment of steroid-refractory acute graft versus host disease with low dose combination monoclonal antibody therapy: A pilot study', Blood, 104, pp. 354A - 354A

Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, 48, pp. 1464 - 1466, http://dx.doi.org/10.1002/art.11071

Van Laar JM; Pavletic SZ; Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, 48, pp. 1463 - 1464, http://dx.doi.org/10.1002/art.10982

Moore JJ; Snowden J; Pavletic S; Barr W; Burt R, 2003, 'Hematopoietic stem cell transplantation for severe rheumatoid arthritis', Bone Marrow Transplantation, 32, pp. 53 - 56

Ponchel F; Papadaki H; Bingham S; Verburg R; Moore JJ; Protheroe A; McGonagle D; Snowden J; Van-Laar J; Markham A; Emery P; Isaacs D, 2003, 'Il-7 and therapy-induced lymphopenia in RA', Annals of the Rheumatic Diseases, 62, pp. 164 - 164

Moore JJ; Milliken ST; Ma DD; Biggs JC, 2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, 48, pp. 1464 - 1466

Brooks P; Moore JJ; Tyndall A, 2003, 'Stem cell transplantation in rheumatic diseases', Journal of Rheumatology, 6, pp. 79 - 82

Moore JJ; Brooks P; Milliken ST; Biggs JC; Ma DD; Handel ML; Will R; Rule S; Joske D; Langlands B; Taylor K; O Callaghan J; Szer J; Wicks I; McColl GJ; Passeullo F; Snowden J, 2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, 46, pp. 2301 - 2309

Brooks P; Moore JJ; Tyndall A, 2002, 'A stem cell transplantation and gene therapy in Rheumatoid diseases', Annals of the Rheumatic Diseases

Moore J; Brooks P, 2001, 'Stem cell transplantation for autoimmune diseases', Springer Seminars in Immunopathology, 23, pp. 193 - 213, http://dx.doi.org/10.1007/s002810100059

Moore JJ; Brooks P, 2001, 'Haemopoietic stem cell transplantation', Springer Seminars in Immunopathology, pp. 193 - 213

Solomon B; Moore JJ; Arthur C; Prince HM, 2001, 'Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomised comparison of urokinase versus heparin', European Journal of Cancer, pp. 2379 - 2384

Moore JJ; Milliken ST; Ma DD; Briggs JW; Brooks P, 2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, 28, pp. 8 - 12

Moore JJ; Tyndall A; Brooks P, 2001, 'Stem cells in the aetiopathogenisis and therapy of rheumatic disease.', Best Practice and Research in Clinical Rheumatology, 15, pp. 711 - 726

Moore J; Aboud M; Ma D, 2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, 84, pp. 735 - 736, http://dx.doi.org/10.1055/s-0037-1614103

Moore J; Coyle L; Isbister J; Roche J, 1999, 'Bilateral knee osteonecrosis in a patient with thrombotic thrombocytopenic purpura', Australian and New Zealand Journal of Medicine, 29, pp. 88 - 89, http://dx.doi.org/10.1111/j.1445-5994.1999.tb01596.x

Moore JJ; Isbister JP; Clifton-Bligh P; Eckstein RP, 1998, 'Calcitriol mediated hypercalcaemia in a T cell rich B cell lymphoma [10]', Australian and New Zealand Journal of Medicine, 28, pp. 479 - 480, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02091.x

Moore J; Ma DDF; Concannon A, 1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, 30, pp. 316 - 318, http://dx.doi.org/10.1080/00313029800169526

Moore J; Ma DD; Concannon A, 1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, 30, pp. 318 - 320, http://dx.doi.org/10.1080/00313029800169536

Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S, 1995, 'Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.', The cancer journal from Scientific American, 1, pp. 252 - 260

Conference Papers

Massey J; Jackson K; Singh M; Hughes B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; Mccaughn G; Moore J; Hamad N, 2022, 'Rate of Menstruation History Taking and Counselling Before, During and After Anticancer Treatments', in AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, WILEY, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000918712800028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J; Jackson K; Singh M; Hughes B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 20 - 20, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899138300042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Penglase R; Visweswaran M; Zaunders J; Girgis L; Ma D; Moore J, 2021, 'Autologous Haematopoietic Stem Cell Transplantation for Systemic Sclerosis Results in Sustained Changes in Immunoregulatory T and NK Cells', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1113 - 1114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cashman H; Hamad N; Moore J; Milliken S; Lavee O; Withers B; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S, 2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-127796

Hardefeldt P; Moore J; Milliken S; Fay K; Orly L; Mayson E; Withers B; Hamad N, 2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-125154

Fleming S; Venn N; Reynolds J; Nguyen U; Kwan J; Moore J; Yeung DT; Leahy MF; Greenwood M; Verner E; Bajel A; Berkahn L; Wei AH; Sutton R, 2019, 'Preliminary Minimal Residual Disease Analysis of the Australasian Leukaemia & Lymphoma Group (ALLG) ALL8 Study of Front-Line Blinatumomab with Chemotherapy in Adults with Ph Negative B-Cell Acute Lymphoblastic Leukaemia', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019, http://dx.doi.org/10.1182/blood-2019-132048

Massey J; Ford C; Khoo M; Cheynier R; Charmantu B; Zaunders J; Hendrawan K; Sutton I; Withers B; Milliken S; Ma D; Moore J, 2019, 'Immune reconstitution following autologous haematopoietic stem cell transplantation for multiple sclerosis is driven by sustained thymic reactivation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GERMANY, Frankfurt, pp. 32 - 33, presented at 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), GERMANY, Frankfurt, 24 March 2019 - 27 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487707800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ford CD; Khoo M; Zaunders J; Massey J; Hendrawan K; Sutton I; Ma DDF; Moore JJ, 2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702802073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ma CKK; Garcia-Cadenas I; Fox L; Ai S; Nivison-Smith I; Milliken ST; Dodds A; Fay K; Ma DDF; Martino R; Sierra J; Moore J, 2018, 'Efficacy of Etanercept in patients with steroid refractory acute graft versus host disease', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 412 - 413, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702804051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Massey J; Sutton I; Ma K; Miliken S; Ma D; Moore J, 2017, 'Autologous haematopoietic stem cell transplantation (aHSCT) in multiple sclerosis (MS) a phase II trial at St Vincent's Hospital, Sydney', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP6 - NP6, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moore J; Ma K; Sutton I; Milliken S; Ma D; Massey J, 2017, 'Autologous stem cell transplantation (ASCT) in relapse remitting (RR-MS) and secondary progressive multiple sclerosis (SP-MS): an Australian-based prospective phase II trial', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, FRANCE, Marseille, pp. S43 - S44, presented at 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), FRANCE, Marseille, 26 March 2017 - 29 March 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424355300048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kenneth B; Link E; Di Iulio J; Szer J; Marlton P; Wei A; Enno A; Schwarer AP; Lewis ID; D'Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn UH; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson WJ; Hertzberg MS; Deveridge SF; Rowlings PA; Mills AK; Gill DS; Bardy PG; Campbell L; Seymour JF, 2016, 'Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), CA, San Diego, 03 December 2016 - 06 December 2016, http://dx.doi.org/10.1182/blood.V128.22.338.338

Dyer G; Gilroy N; Brice L; Greenwood M; Kabir M; Larsen SR; Hertzberg M; Brown L; Hogg M; Huang G; Moore J; Tan J; Kwan J; Ward C; Kerridge I, 2016, 'The experience of survival following Blood and Marrow Transplant in NSW, Australia', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, SPAIN, Valencia, pp. S224 - S225, presented at 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, SPAIN, Valencia, 03 April 2016 - 06 April 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373357600393&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Hertzberg M; Kwan J; Brown L; Huang G; Tan J; Ward C; Kerridge I, 2015, 'FEAR OF CANCER RECURRENCE POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR MALIGNANT DISEASE: ADAPTING TO THE 'NEW NORMAL'', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 110 - 111, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brice L; Gilroy N; Dyer G; Kabbir M; Greenwood M; Larsen S; Moore J; Hertzberg M; Kwan J; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2015, 'HEMATOPOIETIC STEM CELL TRANSPLANTATION, SURVIVORSHIP AND QUALITY OF LIFE: IS IT A SMALL WORLD AFTER ALL?', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 113 - 113, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dyer G; Gifford G; Greenwood M; Gilroy N; Brice L; Kabir M; Larsen S; Hertzberg M; Brown L; Moore J; Tan J; Kwan J; Hogg M; Huang G; Ward C; Kerridge I, 2015, 'THE EXPERIENCE OF SURVIVAL FOLLOWING BLOOD AND MARROW TRANSPLANT IN NSW, AUSTRALIA', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 122 - 122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Oliveira MC; Labopin M; Henes J; Moore J; Del Papa N; Stanciu R; Sakellari I; Schroers R; Scherer HU; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Snowden JA; Farge D, 2014, 'Does Ex Vivo CD34+Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at 56th Annual Meeting of the American-Society-of-Hematology, CA, San Francisco, 06 December 2014 - 09 December 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349243502176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kumarasinghe G; Lavee O; Nivison-Smith I; Parker A; Malouf M; Keogh A; Milliken S; Dodds A; Plit M; Hayward C; Ma D; Fay K; Joseph J; Kotlyar E; Havryk A; Jabbour A; Glanville A; Macdonald P; Moore J, 2014, 'Defining Prognostic Markers in Heart and Lung Transplant Recipients with PTLD', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S84 - S84, presented at 34th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CA, San Diego, 10 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/j.healun.2014.01.260

Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie DS, 2014, 'The Australian Experience with Relapsed Acute Myeloid Leukaemia Post Allogeneic Haematopoietic Stem Cell Transplantation Yields a Simple Prognostic Index for Survival after Relapse', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, TX, Grapevine, pp. S38 - S39, presented at BMT Tandem Meetings, TX, Grapevine, 26 February 2014 - 02 March 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331155400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Khoo M; Carlin S; Lutherborrow M; Ma D; Moore J, 2013, 'GENE ARRAY ANALYSIS OF HUMAN HEMATOPOIETIC STEM CELLS REVEALS ASSOCIATION BETWEEN AGE, ALTERED SIGNALING AND LOSS OF LYMPHOCYTE POTENTIAL', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S33 - S33, presented at 42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), AUSTRIA, Vienna, 22 August 2013 - 25 August 2013, http://dx.doi.org/10.1016/j.exphem.2013.05.130

Kumarasinghe G; Lavee O; Parker A; Keogh A; Hayward C; Kotlyar E; Jabbour A; Havryk A; Malouf M; Plit M; Glanville A; Macdonald P; Moore J, 2013, 'Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CANADA, Montreal, pp. S254 - S254, presented at 33rd Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CANADA, Montreal, 24 April 2013 - 27 April 2013, http://dx.doi.org/10.1016/j.healun.2013.01.657

Ibrahim K; Moore J; Horne A, 2013, 'Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, pp. S184 - S184, presented at BMT Tandem Meetings, UT, Salt Lake City, 13 February 2013 - 17 February 2013, http://dx.doi.org/10.1016/j.bbmt.2012.11.179

He S; Wirth A; Moore J; Szer J; Roberts A; Peppin J; Ritchie D; Grigg A, 2012, 'Rituximab and total nodal irradiation in the treatment of extensive chronic graft-versus-host disease: interim results of a phase 2 study', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, SWITZERLAND, Geneva, pp. S409 - S410, presented at 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), SWITZERLAND, Geneva, 01 April 2012 - 04 April 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000302749201664&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mollee P; Tiley C; Cunningham I; Moore J; Prince M; Cannell P; Gibbons S; Tate J; Paul S; Gill DS, 2011, 'A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, pp. 1700 - 1700, presented at 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, CA, San Diego, 10 December 2011 - 13 December 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299597106142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page